Literature DB >> 28197847

Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types.

Jeong Eun Kim1, Joung-Soon Jang2, Jae-Weon Kim3, Sung Yong Lee4, Chi-Heum Cho5, Myung-Ah Lee6, Do-Jin Kim7, Myung-Ju Ahn8, Kil Yeon Lee9, Sun Jin Sym10, Myong Choel Lim11, Hun Jung12, Cho Eun Kim12, Kyung Wan Min12.   

Abstract

Entities:  

Year:  2017        PMID: 28197847     DOI: 10.1007/s00520-017-3608-9

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  1 in total

1.  Antiemetic regimen with aprepitant in the prevention of chemotherapy-induced nausea and vomiting: An updated systematic review and meta-analysis.

Authors:  Tingting Qiu; Peng Men; Xiaohan Xu; Suodi Zhai; Xiangli Cui
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.